tighter control of blood glucose and lipids to slow the progression of diabetic retinopathy

Prescriber Insights: APRN includes:

• Cutting-edge advice about new medications and how they fit into practice
• Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
• Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote